Deutsche Bank’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$338K Sell
41,573
-4,480
-10% -$36.5K ﹤0.01% 2649
2025
Q1
$362K Sell
46,053
-4,165
-8% -$32.7K ﹤0.01% 2630
2024
Q4
$748K Buy
50,218
+15,995
+47% +$238K ﹤0.01% 2371
2024
Q3
$523K Buy
34,223
+7,557
+28% +$116K ﹤0.01% 2388
2024
Q2
$406K Sell
26,666
-1,637
-6% -$24.9K ﹤0.01% 2399
2024
Q1
$534K Buy
28,303
+86
+0.3% +$1.62K ﹤0.01% 2284
2023
Q4
$539K Buy
28,217
+1,363
+5% +$26K ﹤0.01% 2315
2023
Q3
$482K Buy
26,854
+3,380
+14% +$60.7K ﹤0.01% 2175
2023
Q2
$477K Sell
23,474
-11,032
-32% -$224K ﹤0.01% 2397
2023
Q1
$629K Sell
34,506
-18,247
-35% -$333K ﹤0.01% 2360
2022
Q4
$1.09M Sell
52,753
-149,412
-74% -$3.09M ﹤0.01% 2000
2022
Q3
$5.29M Sell
202,165
-5,166
-2% -$135K ﹤0.01% 1186
2022
Q2
$5.25M Buy
207,331
+6,195
+3% +$157K ﹤0.01% 1254
2022
Q1
$6.35M Sell
201,136
-2,357
-1% -$74.4K ﹤0.01% 1287
2021
Q4
$8.24M Buy
203,493
+992
+0.5% +$40.1K ﹤0.01% 1187
2021
Q3
$7.06M Sell
202,501
-29,637
-13% -$1.03M ﹤0.01% 1317
2021
Q2
$6.38M Buy
232,138
+96,200
+71% +$2.64M ﹤0.01% 1385
2021
Q1
$3.82M Buy
135,938
+100,345
+282% +$2.82M ﹤0.01% 1706
2020
Q4
$925K Buy
35,593
+9,697
+37% +$252K ﹤0.01% 2485
2020
Q3
$443K Sell
25,896
-18,745
-42% -$321K ﹤0.01% 2690
2020
Q2
$1.1M Buy
44,641
+25,626
+135% +$634K ﹤0.01% 2145
2020
Q1
$264K Sell
19,015
-12,559
-40% -$174K ﹤0.01% 2795
2019
Q4
$318K Sell
31,574
-17,451
-36% -$176K ﹤0.01% 2935
2019
Q3
$445K Buy
49,025
+11,756
+32% +$107K ﹤0.01% 2716
2019
Q2
$294K Sell
37,269
-2,094
-5% -$16.5K ﹤0.01% 3555
2019
Q1
$490K Sell
39,363
-1,623
-4% -$20.2K ﹤0.01% 3420
2018
Q4
$439K Buy
40,986
+19,919
+95% +$213K ﹤0.01% 3388
2018
Q3
$293K Buy
21,067
+10,986
+109% +$153K ﹤0.01% 3985
2018
Q2
$124K Buy
+10,081
New +$124K ﹤0.01% 4303